Long intergenic non-protein coding RNA 1716 (LINC01716)

Long intergenic non-protein coding RNA 1716 (LINC01716) is a long intergenic non-coding RNA (lincRNA) gene, which refers to a class of non-protein coding RNA transcripts located between protein coding genes in the genome[1][3][5]. While lincRNAs such as LINC01716 are involved in the regulation of gene expression at multiple levels including epigenetic, transcriptional, and post-transcriptional processes, there is no evidence from current major biological databases or literature suggesting that LINC01716 is itself a validated therapeutic target, biomarker, or disease-associated gene[1][3][5]. No direct roles in human disease or drug interactions have been documented for LINC01716. LINC01716 should not be confused with LINC01116, which is a distinct long non-coding RNA with significant cancer relevance[2][4]. As of the current data, LINC01716 does not appear in therapeutic target pipelines, clinical biomarker panels, or drug interaction studies[1][3]. The function of LINC01716 itself remains to be experimentally characterized in the literature.

Other names

LINC01716